In addition to maintaining airway and circulatory system patency, the single most important step in management of carcinoid crisis is the prompt administration of intravenous octreotide, a somatostatin analog which directly inhibits the release of vasoactive amines from tumor cells, while simultaneously acting as a somatostatin analog to inhibit splanchnic blood flow and the release of other hormones, such as insulin and glucagon (Dhanani et al. 2020; Baradasi et al. 2022). This evidence concerns the gene INS and neoplasm.